|
CHRNA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64701585703142E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16140003064902E-10 |
| Normal-vs-Stage2 |
4.034000E-02 |
| Normal-vs-Stage3 |
2.197000E-04 |
| Normal-vs-Stage4 |
4.300000E-02 |
| Stage1-vs-Stage2 |
5.532000E-01 |
| Stage1-vs-Stage3 |
2.651900E-02 |
| Stage1-vs-Stage4 |
7.425700E-02 |
| Stage2-vs-Stage3 |
2.796400E-01 |
| Stage2-vs-Stage4 |
9.690400E-02 |
| Stage3-vs-Stage4 |
1.515180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.88420012504321E-10 |
| Normal-vs-AfricanAmerican |
1.555060E-04 |
| Normal-vs-Asian |
3.870300E-02 |
| Caucasian-vs-AfricanAmerican |
8.264600E-01 |
| Caucasian-vs-Asian |
1.689440E-01 |
| AfricanAmerican-vs-Asian |
8.905900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04987154922765E-12 |
| Normal-vs-Female |
2.5197999999893E-06 |
| Male-vs-Female |
3.980400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.280000E-02 |
| Normal-vs-Extreme_Weight |
2.94460011929232E-10 |
| Normal-vs-Obese |
4.06339999999838E-05 |
| Normal-vs-Extreme_Obese |
3.085600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.899180E-01 |
| Normal_Weight-vs-Obese |
5.437400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.225800E-02 |
| Extreme_Weight-vs-Obese |
1.481240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.066200E-02 |
| Obese-vs-Extreme_Obese |
6.317000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.241600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.88698999999959E-05 |
| Normal-vs-Age(61-80Yrs) |
1.58449997567089E-09 |
| Normal-vs-Age(81-100Yrs) |
1.046130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.473900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.592100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.862340E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.513400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.608420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.92249549613166E-11 |
| Normal-VS-Type2 PRCC |
1.161690E-04 |
| Normal-VS-KIRP CIMP |
4.801200E-03 |
| Normal-VS-Unclassified PRCC |
1.644810E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.476300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.739500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.865800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.153700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.369200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.179820E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.217400E-04 |
| Normal-vs-N1 |
9.83169999999589E-05 |
| Normal-vs-N2 |
1.707750E-01 |
| N0-vs-N1 |
2.999500E-03 |
| N0-vs-N2 |
2.016000E-01 |
| N1-vs-N2 |
3.201000E-01 |
|
|
